Table 1.
Clinical findings and laboratory results.
| On admission | Final examination | |
|---|---|---|
| Age | 34 months | 7.2 years |
| Weight (kg)/weight-SDS | 17.2/1.3 | 28.3/1.1 |
| Height (cm)/height-SDS | 97.5/0.5 | 123.7/0.3 |
| BMI (kg/m2)/BMI-SDS | 18/1.30 | 18.5/1.4 |
| Tanner stage (pubic hair development) | 1 | 1 |
| Testes volumes | Testes 2/2 mL | Testes 2/2 mL |
| Laboratory tests (reference ranges) | ||
| FBG (60–100 mg/dL) | 65 | 90 |
| Na (135–145 mmol/L) | 142 | 140 |
| K (3.5–5 mmol/L) | 4.6 | 4.9 |
| ACTH (6–48 pg/mL) | <5 | – |
| Cortisol (3–21 μg/dL) | 0.9 | – |
| TSH (0.6–5.5 μIU/mL) | 1.2 | 2.6 |
| fT4 (0.85–1.75 ng/dL) | 1.2 | 1 |
| PRL (3–18 ng/mL) | 16.1 | 16.3 |
| DHEAS (13–83 μg/dL) | 21 | |
| A4 (10–17 ng/dL) | 13 | – |
| 17α-OHP (<91 ng/dL) | 11 | – |
| Peak cortisol response to low-dose (1 µg) ACTH stimulation test (≥18 μg/dL) | 0.1 | – |
| Karyotype | 46, XY | |
| Bone age (years) | 2 | 7 |
| Adrenal USG | Normal | |
| Cranial and pituitary MRI | Normal | |
ACTH, adrenocorticotropic hormone; A4, androstenedione; BMI, body mass index; DHEAS, dehydroepiandrosterone sulfate; FBG, fasting blood glucose; fT4, free thyroxine; K, potassium; Na, sodium; MRI, magnetic resonance imaging; PRL, prolactin; SDS, standard deviation score; TSH, thyroid-stimulating hormone; USG, ultrasonography; 17α-OHP, 17α-hydroxyprogesterone (abnormal findings are shown in bold).